Hsbc Holdings PLC Sorrento Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $50,420 - $96,166	-33,391 Reduced 20.77%	127,342 $205,000
Q2 2022 Aug 11, 2022	BUY	$1.24 - $2.33 $160,250 - $301,115	129,234 Added 410.28%	160,733 $326,000
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $1,720 - $4,214	860 Added 2.81%	31,499 $75,000
Q4 2021 Feb 11, 2022	BUY	$4.65 - $7.23 $76,036 - $118,224	16,352 Added 114.45%	30,639 $142,000
Q3 2021 Nov 12, 2021	SELL	$7.41 - $10.99 $8,951 - $13,275	-1,208 Reduced 7.8%	14,287 $108,000
Q2 2021 Aug 13, 2021	BUY	$6.35 - $10.0 $98,393 - $154,950	15,495 New	15,495 $150,000
Q1 2021 May 14, 2021	SELL	$7.03 - $16.51 $201,571 - $473,391	-28,673 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$5.76 - $11.95 $165,156 - $342,642	28,673 New	28,673 $195,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $4.17 $14,549 - $41,841	-10,034 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.05 - $2.69 $20,569 - $26,991	10,034 New	10,034 $21,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.